It makes sense that something like salt would hinder a bacteria or virus etc.
I dont understand the chemistry of this Drug at all, but re-purposing existing drugs sounds like an absolute cash cow of a Business Model.
I assume PAR would have to pay a royalty to any existing drug company and then take a skim profit from the boost in sales.
Im just speculating but this seems a Credible business model with a strong future.
It makes sense that something like salt would hinder a bacteria...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.055(20.4%) |
Mkt cap ! $82.30M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 33.5¢ | 27.5¢ | $1.328M | 4.323M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4624 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 152597 | 4 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
